2026 National Research Funding Competitions

Four regenerative medicine research programs are available that focus on innovation, translation toward the clinic, and policy and societal impact:

• Accelerating Clinical Translation Awards (up to $700,000)
  • Support multi-disciplinary research that is moving toward the clinic within five years; or is addressing a key research question associated with an ongoing clinical trial.
  • Joint-Funded Awards valued at $840,000 are also available in collaboration with Azrieli Foundation or Breakthrough T1D.

• Early Career Researcher Jump Start Awards (up to $270,000)
  • For early career researchers (within the first five years of an initial academic appointment) to develop a research program with a regenerative medicine focus.
  • Joint-Funded Awards valued at $324,000 are also available in collaboration with Azrieli Foundation.
     
• Impact Awards (up to $290,000)
  • Support proof-of-principle experiments, including novel therapeutic or technical approach development that will drive regenerative medicine therapies forward.
  • Joint-Funded Awards valued at $348,000 are also available in collaboration with Azrieli Foundation or Breakthrough T1D.
     
• Impact Awards: Ethical, Legal, and Social Implications (ELSI) & Health Economics (HE) Stream (up to $215,000)
  • Support the knowledge generation and/or translation of regenerative medicine research for targeted stakeholders and/or users. 
  • Joint-Funded Awards valued at $258,000 are also available in collaboration with Azrieli Foundation or Breakthrough T1D.